Mechanism of Action

By activating GLP-1 receptors and reducing the effects of GIP, Tirzepatide can improve glycemic control, promote weight loss, and improve insulin sensitivity. A subcutaneous Tirzepatide injection has been shown to be safe and effective in clinical studies.

Class of Compound

Peptide

Street Names

Tirzepatide

Effects

Improved glycemic control and weight loss

Side Effects and Dangers

Nausea, Diarrhea, Vomiting, and Decreased appetite

Top Studies

• Farzam K, Patel P. Tirzepatide. [Updated 2022 Dec 27]. In: StatPearls [Internet]. Treasure Island (FL)

• Juan P. Frias et al., Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes, The New England Journal of Medicine